Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline

INTRODUCTION: There are no blood-based biomarkers for cognitive decline in aging, or mild cognitive impairment (MCI) and Alzheimer's disease (AD). Cumulative evidence suggests that apolipoproteins, complement system, and transthyretin are involved in AD pathogenesis by sequestration of amyloid...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Kazuhiko, Shan, Liu, Suzuki, Hideaki, Tabuse, Yo, Nishimura, Yoshinori, Hirokawa, Yoshihiro, Mizukami, Katsuyoshi, Akatsu, Hiroyasu, Meno, Kohji, Asada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876892/
https://www.ncbi.nlm.nih.gov/pubmed/27239510
http://dx.doi.org/10.1016/j.dadm.2015.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876892/
https://www.ncbi.nlm.nih.gov/pubmed/27239510
http://dx.doi.org/10.1016/j.dadm.2015.04.003

Ejemplares similares